Brimonidine Tartrate/Timolol
Brand name: Brimonidine Tartrate-Timolol
Rank #133 of 500 drugs by total cost
Data: CMS Medicare Part D, 2023 (most current available) · Updated March 2026
$122.0M
Total Cost
361,001
Total Claims
$122.0M
Total Cost
9,739
Prescribers
$338
Cost per Claim
63,535
Beneficiaries
576,849
30-Day Fills
$13K
Avg Cost/Provider
37
Avg Claims/Provider
Share of Medicare Part D Spending
0.04%
of total Medicare Part D spending
$122.0M of $275.65B
Top Prescribers by Cost
Top 10 prescribers of $122.0M total
Top Prescribers of Brimonidine Tartrate/Timolol
| # | Provider | Specialty | Location | Claims | Cost |
|---|---|---|---|---|---|
| 1 | Fiaz Zaman | Ophthalmology | Houston, TX | 957 | $478K |
| 2 | Analisa Arosemena | Ophthalmology | Miami Beach, FL | 1,353 | $478K |
| 3 | Mark Fromer | Ophthalmology | New York, NY | 733 | $351K |
| 4 | Howard Kushnick | Ophthalmology | Allentown, PA | 732 | $329K |
| 5 | Eric Gechter | Ophthalmology | Ft Lauderdale, FL | 1,059 | $308K |
| 6 | Scott Schecter | Optometry | Fort Lauderdale, FL | 1,091 | $294K |
| 7 | Milton Hearing | Optometry | Palm Springs, FL | 1,148 | $291K |
| 8 | John Aey | Ophthalmology | Youngstown, OH | 619 | $290K |
| 9 | Douglas Day | Ophthalmology | Atlanta, GA | 590 | $287K |
| 10 | Nathan Radcliffe | Ophthalmology | New York, NY | 477 | $273K |
| 11 | Kundandeep Nagi | Ophthalmology | San Antonio, TX | 605 | $244K |
| 12 | Kevin Freeman | Ophthalmology | Riverdale, GA | 434 | $241K |
| 13 | Nehal Patel | Ophthalmology | Mcallen, TX | 486 | $223K |
| 14 | Bingjing Roberts | Ophthalmology | New York, NY | 880 | $214K |
| 15 | Jeremy Cotliar | Ophthalmology | New York, NY | 419 | $212K |
Top prescribers ranked by total cost for this drug in 2023.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 130 | Immun Globg(Igg)/Malt/Iga Ov50 (Octagam) | $129.5M | 9,657 |
| 131 | Pregabalin (Pregabalin) | $124.3M | 2,696,923 |
| 132 | Dronedarone Hcl (Multaq) | $123.4M | 98,156 |
| 133 | Brimonidine Tartrate/Timolol (Brimonidine Tartrate-Timolol) | $122.0M | 361,001 |
| 134 | Olaparib (Lynparza) | $121.1M | 8,744 |
| 135 | Empagliflozin/Metformin Hcl (Synjardy Xr) | $119.7M | 121,366 |
| 136 | Edaravone (Radicava Ors) | $119.6M | 8,588 |
Related Analysis
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology